Skip to main content Skip to navigation
Purified Rat Anti-Human G-CSF
Alert icon
This SKU will be discontinuing Apr 2024. For additional support, contact your local applications specialist. Contact Us #
Product Details
Down Arrow Up Arrow

BD Pharmingen™
Human (QC Testing)
Rat IgG1
E. coli-expressed human G-CSF
ELISA Capture (Routinely Tested), Western blot (Reported)
1.0 mg/ml
Aqueous buffered solution containing ≤0.09% sodium azide.

Preparation And Storage

The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. Store undiluted at 4°C.

Recommended Assay Procedures

ELISA Capture: The purified BVD13-3A5 antibody (Cat. No. 551342) is useful as a capture antibody for a sandwich ELISA for measuring human G-CSF protein levels.  Purified BVD13-3A5 antibody can be paired with the biotinylated BVD11-37G10 antibody (Cat. No. 554670) as the detecting antibody, with recombinant human G-CSF as the standard. Purified BVD13-3A5 antibody should be titrated 1-4 µg/ml to determine optimal concentration for ELISA capture. To obtain linear standard curves, doubling dilutions of human BVD13-3A5 ranging from ~2,000 to 15 pg/ml are recommended for inclusion in each ELISA plate. For specific methodology, please visit our web site, and go to the protocols section or refer to the chapter on ELISA in the Immune Function Handbook both of which can be found at

WB: The BVD13-3A5 antibody (Cat. No. 551342) has been found useful for Western blotting. A concentration of 1-5 µg/ml has been found to enable visualization of ≤ 100 ng/lane of recombinant human G-CSF, under reducing conditions.

Product Notices

  1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  2. Please refer to for technical protocols.
  3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
551342 Rev. 1
Antibody Details
Down Arrow Up Arrow

The BVD13-3A5 antibody reacts with human granulocyte-colony stimulating factor (G-CSF).  The immunogen used to generate the hybridoma was E. coli-expressed human G-CSF. This is a neutralizing antibody.

551342 Rev. 1
Format Details
Down Arrow Up Arrow
Tissue culture supernatant is purified by either protein A/G or affinity purification methods. Both methods yield antibody in solution that is free of most other soluble proteins, lipids, etc. This format provides pure antibody that is suitable for a number of downstream applications including: secondary labeling for flow cytometry or microscopy, ELISA, Western blot, etc.
551342 Rev.1
Citations & References
Down Arrow Up Arrow

Development References (2)

  1. Abrams J. Immunoenzymetric assay of mouse and human cytokines using NIP-labeled anti-cytokine antibodies. Curr Protoc Immunol. 2001; 1:6.20-6.21. (Clone-specific: ELISA). View Reference
  2. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev. 1992; 127:5-24. (Clone-specific: ELISA). View Reference
551342 Rev. 1

Please refer to Support Documents for Quality Certificates

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.